Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats

被引:38
作者
Kowluru, RA [1 ]
Kowluru, A
Chakrabarti, S
Khan, Z
机构
[1] Wayne State Univ, Kresge Eye Inst, Detroit, MI 48201 USA
[2] Univ Western Ontario, London, ON, Canada
关键词
D O I
10.2337/diabetes.53.3.775
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hyperglycemia is thought to be the underlying factor in the development of diabetic retinopathy, but the mechanisms involved remain partially understood. Diabetes increases oxidative stress, and reactive oxygen species affect the interactions between a small-molecular-weight G-protein, H-Ras, and several of its effector proteins. The purpose of this study was to examine the regulatory role of H-Ras in glucose-induced apoptosis of retinal endothelial cells. The expressions of H-Ras and its effector protein (Raf-1) were compared in the retina obtained from diabetic rats (2-8 months' duration) and age-matched normal rats and in retinal endothelial cells exposed to high-glucose medium. The effect of inhibition of H-Ras function on glucose-induced capillary cell death and the potential involvement of oxidative stress in diabetes-induced activation of H-Ras were also determined. The expressions of H-Ras and Raf-1 were increased in the retina in diabetes, and antioxidant therapy prevented diabetes-induced increased protein and mRNA expressions. The inhibitors of Ras farnesylation inhibited glucose-induced nitric oxides and apoptosis in isolated retinal endothelial cells. Thus, the results suggest that functional activation of H-Ras might be one of the signaling steps involved in glucose-induced capillary cell apoptosis and supports the role of H-Ras in the development of retinopathy in diabetes.
引用
收藏
页码:775 / 783
页数:9
相关论文
共 50 条
[1]   The Ras GDP/GTP cycle is regulated by oxidizing agents at the level of Ras regulators and effectors [J].
Accorsi, K ;
Giglione, C ;
Vanoni, M ;
Parmeggiani, A .
FEBS LETTERS, 2001, 492 (1-2) :139-+
[2]   Vascular endothelial growth factor and the eye: Biochemical mechanisms of action and implications for novel therapies [J].
Aiello, LP .
OPHTHALMIC RESEARCH, 1997, 29 (05) :354-362
[3]  
Amin R, 2003, DIABETES, V52, pA365
[4]   Inhibition of glucose- and calcium-induced insulin secretion from βTC3 cells by novel inhibitors of protein isoprenylation [J].
Amin, R ;
Chen, HQ ;
Tannous, M ;
Gibbs, R ;
Kowluru, A .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (01) :82-88
[5]  
Armstrong Donald, 1992, Journal of Diabetes and its Complications, V6, P116, DOI 10.1016/1056-8727(92)90022-D
[6]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[7]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[8]   Differential activation of NF-κB and AP-1 in increased fibronectin synthesis in target organs of diabetic complications [J].
Chen, SL ;
Khan, ZA ;
Cukiernik, M ;
Chakrabarti, S .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (06) :E1089-E1097
[9]   Reactive oxygen species mediate cyclic strain-induced endothelin-1 gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in endothelial cells [J].
Cheng, TH ;
Shih, NL ;
Chen, SY ;
Loh, SH ;
Cheng, PY ;
Tsai, CS ;
Liu, SH ;
Wang, DL ;
Chen, JJ .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (10) :1805-1814
[10]   Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy [J].
Cooper, ME .
DIABETOLOGIA, 2001, 44 (11) :1957-1972